Buys
Open market- Shares
- +3
- Avg price
- $195.04
- Total value
- +$585
Nicole Murphy - Head of Pharm Ops and Tech at BIOGEN INC.
Issuer-level insider activity
- Role
- Head of Pharm Ops and Tech
- Issuer ticker
- BIIB on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Nicole Murphy in BIOGEN INC.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +3
- Share %
- 100%
- Total value
- +$585
Reported holdings for Nicole Murphy in BIOGEN INC.
Form 4 holding
Head of Pharm Ops and Tech
BIOGEN INC.
- Security class
- Common Stock
- Shares / value
- 19,611
- Estimated value
- $3,824,839
- Report date
- 12 Feb 2026
- Price
- $195.04
- Ownership
- Direct
Form 4 holding
Head of Pharm Ops and Tech
BIOGEN INC.
- Security class
- Restricted Stock Unit
- Shares / value
- 10,560
- Estimated value
- $0
- Report date
- 13 Feb 2026
- Price
- $142.54
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Nicole Murphy in BIOGEN INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.